Leerink Partners Raises Price Target on Insulet (PODD) to $50; Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Wedbush Raises Price Target on Insulet (PODD) to $48 Following 2Q Beat
August 4, 2016 10:01 AM EDTWedbush reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), and raised the price target to $48.00 (from $44.00), following the company's 2Q earnings report. Revenues of $87 million were $4 million ahead of consensus. EPS of ($0.07) was 10c better than consensus.
Analyst Tao Levy commented,... More
Insulet Corporation (PODD) PT Raised to $46 at Piper Jaffray
August 4, 2016 6:52 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and raised his price target on Insulet Corporation (NASDAQ: PODD) to $46.00 (from $41.00) following strong Q2 results.
West commented, "Insulet posted 2Q16 revenues of $87.3M (+44% proforma), 5%+ above the consensus estimate of $83.0M, primarily on strength in... More
After-Hours Stock Movers 08/03: (SQ) (PODD) (JACK) Higher; (TDOC) (SGMO) (FRSH) Lower (more...)
August 3, 2016 6:52 PM EDTToday's After-Hours Movers
Teladoc (NYSE: TDOC) 24% LOWER; reported Q2 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $28.2 million. Teladoc sees Q3 2016 EPS of ($0.35)-($0.38), versus the consensus of ($0.27). Teladoc sees Q3 2016 revenue of $32-33 million, versus the consensus of $32.96 million. Teladoc sees FY2016 EPS of ($1.47)-($1.52), versus the consensus of ($1.28). Teladoc sees FY2016 revenue of $121-124 million, versus the consensus of $126.43 million.
Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance
August 3, 2016 4:04 PM EDTInsulet (NASDAQ: PODD) reported Q2 EPS of ($0.08), $0.09 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $87.3 million versus the consensus estimate of $81.1 million.
GUIDANCE:
Insulet sees Q3 2016 revenue of $88-91 million, versus the consensus of $87... More
Trading Radar for 8/3: Tesla (TSLA), Humana (HUM), Herbalife (HLF), GoDaddy (GDDY), Metlife (MET) Report
August 2, 2016 2:21 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:!5am EDT
Earnings:
3D Systems (NYSE: DDD) - consensus EPS $0.06
ALLETE, Inc. (NYSE: ALE) - consensus EPS $0.53
Agilysys, Inc. (Nasdaq: AGYS) - consensus loss $0.08
Almost Family (Nasdaq: AFAM) - consensus EPS $0.64
Ampco-Pittsburgh (NYSE: AP) - no... More

